Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective Ep4 Receptor Antagonism.
From: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. li.yang@vanderbilt.edu
Cancer research
- Publish Date: Oct 2006
- ISSN: 1538-7445
- Volume: 66
- Issue: 19
- Pages: 9665-72
- Medium: Internet
- Language: English
- Citation (JAMA): Yang Li, Huang Yuhui, Porta Rut, et al. Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective Ep4 Receptor Antagonism.. Cancer Res. Oct 2006;66:9665-72
Abstract
Prostaglandin E(2) (PGE(2)), one of the major metabolites of cyclooxygenase-2, has been implicated in tumorigenesis and tumor progression in several human cancers, including colorectal and lung. Here, we show that one of the PGE(2) receptors, the EP4 receptor, plays an important role in metastasis in both of these tumor types. Using i.v. injected Lewis lung carcinoma (3LL), we found that tumor metastasis to lung was significantly reduced when mice were treated with a specific EP4 antagonist ONO-AE3-208 or when EP4 receptor expression was knocked down in the tumor cells using RNA interference technology. Host EP4 receptors also contributed to tumor metastasis and tumor growth with decreased metastasis and tumor growth observed in EP4 receptor knockout animals. In vitro tumor cell adhesion, motility, invasion, colony formation, and Akt phosphorylation were all significantly inhibited when 3LL cells were treated with the EP4 receptor-specific antagonist. When the cells were treated with an EP4-specific agonist (AE1-734), we observed a worsening of these same features in vitro. Treatment with ONO-AE3-208 also profoundly decreased liver metastases after intrasplenic injection of MC26 colon cancer cells. Our data show that selective antagonism of EP4 receptor signaling results in a profound reduction in lung and colon cancer metastasis. Selective antagonism of the EP4 receptor may thus represent a novel therapeutic approach for the treatment of cancer and especially its propensity to metastasize.
Mesh Headings (Keywords): Animals, Antineoplastic Agents, Carcinoma, Lewis Lung, Cell Adhesion, Cell Line, Tumor, Colorectal Neoplasms, Dinoprostone, Drug Screening Assays, Antitumor, Female, Heptanoates, Liver Neoplasms, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Naphthalenes, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Phenylbutyrates, RNA, Small Interfering, Receptors, Prostaglandin E, Specific Pathogen-Free Organisms, Transfection, Tumor Stem Cell Assay
Check for Full Text / PubMed Unique Identifier (PMID): 17018624
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.